Kinase activity of mutant LRRK2 mediates neuronal toxicity
Top Cited Papers
- 17 September 2006
- journal article
- research article
- Published by Springer Nature in Nature Neuroscience
- Vol. 9 (10), 1231-1233
- https://doi.org/10.1038/nn1776
Abstract
Mutations in the the leucine-rich repeat kinase-2 (LRRK2) gene cause autosomal-dominant Parkinson disease and some cases of sporadic Parkinson disease. Here we found that LRRK2 kinase activity was regulated by GTP via the intrinsic GTPase Roc domain, and alterations of LRRK2 protein that reduced kinase activity of mutant LRRK2 correspondingly reduced neuronal toxicity. These data elucidate the pathogenesis of LRRK2-linked Parkinson disease, potentially illuminate mechanisms of sporadic Parkinson disease and suggest therapeutic targets.Keywords
This publication has 14 references indexed in Scilit:
- Kinase activity is required for the toxic effects of mutant LRRK2/dardarinNeurobiology of Disease, 2006
- LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domainCellular Signalling, 2006
- Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degenerationProceedings of the National Academy of Sciences, 2005
- The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activityHuman Molecular Genetics, 2005
- Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activityProceedings of the National Academy of Sciences, 2005
- LRRK2 mutations in Parkinson diseaseNeurology, 2005
- Genetics of Parkinsonʼs diseaseCurrent Opinion in Neurology, 2005
- Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's DiseaseNeuron, 2004
- Identification of Residues in the Human Guanylate-binding Protein 1 Critical for Nucleotide Binding and Cooperative GTP HydrolysisJournal of Molecular Biology, 2004
- Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic PathologyNeuron, 2004